• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

No alteration of voriconazole concentration by plasmapheresis in a critically ill patient.

作者信息

Vay Manuela, Foerster Kathrin I, Mahmoudi Mazyar, Seeßle Jessica, Mikus Gerd

机构信息

Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.

Department of Gastroenterology, Infectious Diseases, Intoxication, Heidelberg University Hospital, Im Neuenheimer Feld 410, 60120, Heidelberg, Germany.

出版信息

Eur J Clin Pharmacol. 2019 Feb;75(2):287-288. doi: 10.1007/s00228-018-2582-6. Epub 2018 Oct 22.

DOI:10.1007/s00228-018-2582-6
PMID:30349944
Abstract
摘要

相似文献

1
No alteration of voriconazole concentration by plasmapheresis in a critically ill patient.在一名危重病患者中，血浆置换未改变伏立康唑的浓度。
Eur J Clin Pharmacol. 2019 Feb;75(2):287-288. doi: 10.1007/s00228-018-2582-6. Epub 2018 Oct 22.
2
Significance of monitoring plasma concentration of voriconazole in a patient with liver failure: A case report.监测肝衰竭患者伏立康唑血药浓度的意义：一例报告
Medicine (Baltimore). 2017 Oct;96(42):e8039. doi: 10.1097/MD.0000000000008039.
3
Management of Aspergillus pleural empyema with combined systemic and intrapleural antifungal therapy in a pediatric patient: Case report.儿童患者合并全身和胸膜内抗真菌治疗曲霉性脓胸的管理：病例报告。
J Infect Public Health. 2018 Mar-Apr;11(2):280-282. doi: 10.1016/j.jiph.2017.04.003. Epub 2017 May 22.
4
Voriconazole therapeutic drug monitoring in critically ill patients improves efficacy and safety of antifungal therapy.重症患者伏立康唑治疗药物监测可提高抗真菌治疗的疗效和安全性。
Basic Clin Pharmacol Toxicol. 2020 Dec;127(6):495-504. doi: 10.1111/bcpt.13465. Epub 2020 Jul 20.
5
Pulmonary infiltrate with characteristic "reversed halo" and "air crescent" signs.肺部浸润伴特征性的“反晕征”和“空气新月征”。
Eur J Intern Med. 2017 Jun;41:e3-e4. doi: 10.1016/j.ejim.2016.12.005. Epub 2016 Dec 12.
6
Impact of hypoalbuminemia on voriconazole pharmacokinetics in critically ill adult patients.低白蛋白血症对危重症成年患者伏立康唑药代动力学的影响。
Antimicrob Agents Chemother. 2014 Nov;58(11):6782-9. doi: 10.1128/AAC.03641-14. Epub 2014 Sep 2.
7
Key Elements in Determining Voriconazole Protein Binding Characteristics: Comment on "Determination of Plasma Unbound Fraction of Voriconazole in Patients Treated With a Prophylactic or a Curative Treatment".确定伏立康唑蛋白结合特性的关键要素：评“接受预防性或治疗性治疗患者伏立康唑血浆游离分数的测定”
Ther Drug Monit. 2015 Aug;37(4):551-3. doi: 10.1097/FTD.0000000000000163.
8
Invasive pulmonary aspergillosis after near-drowning.近乎溺水后发生的侵袭性肺曲霉病
Lancet Infect Dis. 2016 Dec;16(12):1430. doi: 10.1016/S1473-3099(16)30202-X. Epub 2016 Nov 15.
9
Therapeutic drug monitoring of voriconazole helps to decrease the percentage of patients with off-target trough serum levels.伏立康唑的治疗药物监测有助于降低目标谷浓度不达标的患者比例。
Med Mycol. 2016 May;54(4):353-60. doi: 10.1093/mmy/myv099. Epub 2016 Jan 6.
10
Invasive Aspergillus infection requiring lobectomy in a CYP2C19 rapid metabolizer with subtherapeutic voriconazole concentrations.在一名CYP2C19快速代谢型患者中，侵袭性曲霉感染需要进行肺叶切除术，其伏立康唑浓度低于治疗水平。
Pharmacogenomics. 2016 May;17(7):663-7. doi: 10.2217/pgs-2015-0014. Epub 2016 May 4.

引用本文的文献

1
Effect of therapeutic plasma exchange on antimicrobials in critically ill patients.治疗性血浆置换对重症患者抗菌药物的影响。
Crit Care. 2024 Aug 28;28(1):280. doi: 10.1186/s13054-024-05077-w.
2
Drug Dosing in Patients Undergoing Therapeutic Plasma Exchange.治疗性血浆置换患者的药物剂量。
Neurocrit Care. 2021 Feb;34(1):301-311. doi: 10.1007/s12028-020-00989-1.

本文引用的文献

1
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.曲霉病诊断和管理实践指南：美国感染病学会2016年更新版
Clin Infect Dis. 2016 Aug 15;63(4):e1-e60. doi: 10.1093/cid/ciw326. Epub 2016 Jun 29.
2
How to manage aspergillosis in non-neutropenic intensive care unit patients.如何管理非中性粒细胞减少的重症监护病房患者的曲霉病。
Crit Care. 2014 Jul 25;18(4):458. doi: 10.1186/s13054-014-0458-4.
3
Protein-binding characteristics of voriconazole determined by high-throughput equilibrium dialysis.
通过高通量平衡透析法测定伏立康唑的蛋白结合特性。
J Pharm Sci. 2014 Aug;103(8):2565-70. doi: 10.1002/jps.24064. Epub 2014 Jun 24.
4
Pharmacokinetic profile of voriconazole in a critically ill patient on therapeutic plasma exchange.伏立康唑在接受治疗性血浆置换的危重症患者中的药代动力学特征。
Ther Drug Monit. 2013 Feb;35(1):141-3. doi: 10.1097/FTD.0b013e31827d76b0.
5
Challenging recommended oral and intravenous voriconazole doses for improved efficacy and safety: population pharmacokinetics-based analysis of adult patients with invasive fungal infections.挑战推荐的口服和静脉伏立康唑剂量以提高疗效和安全性：基于群体药代动力学分析成人侵袭性真菌感染患者。
Clin Infect Dis. 2012 Aug;55(3):381-90. doi: 10.1093/cid/cis437. Epub 2012 May 18.
6
Drug removal by plasmapheresis: an evidence-based review.血浆置换清除药物：一项基于证据的综述。
Pharmacotherapy. 2007 Nov;27(11):1529-49. doi: 10.1592/phco.27.11.1529.
7
Pharmacokinetic/pharmacodynamic profile of voriconazole.伏立康唑的药代动力学/药效学特征
Clin Pharmacokinet. 2006;45(7):649-63. doi: 10.2165/00003088-200645070-00002.
8
Extracorporeal removal of antimicrobials during plasmapheresis.血浆置换过程中抗菌药物的体外清除。
J Clin Apher. 2003;18(4):194-205. doi: 10.1002/jca.10074.